Status:
COMPLETED
Registry for Primary Ciliary Dyskinesia
Lead Sponsor:
University of Alberta
Conditions:
Primary Ciliary Dyskinesia
Eligibility:
All Genders
Brief Summary
Primary Ciliary Dyskinesia (PCD) is a rare disease, which means that any single PCD center has experience with a limited number of patients. PCD Registry is the collection of data about PCD from many ...
Detailed Description
In order to better characterize the clinical course, and improve the diagnosis and treatment of PCD, the investigators propose to establish a provincial PCD registry in Alberta. This registry will be ...
Eligibility Criteria
Inclusion
- Clinical diagnosis of PCD
- Abnormal findings in at least two of the following tests:
- High-frequency video microscopic finding, transmission electron microscopy finding, immunofluorescence finding, low nasal NO concentration/production, demonstration of biallelic disease-causing mutations by genotyping.
Exclusion
- • Failure or unwillingness to give written informed consent.
Key Trial Info
Start Date :
August 26 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 25 2021
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT03271840
Start Date
August 26 2017
End Date
November 25 2021
Last Update
June 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alberta
Edmonton, Alberta, Canada, T6G2C6